Galectin Therapeutics Inc. (GALT)

Galectin Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	13.77	15.12	25.66	18.59	39.65	27.14
Cash & Short-Term Investments	13.77	15.12	25.66	18.59	39.65	27.14
Cash Growth	-46.20%	-41.08%	38.02%	-53.11%	46.08%	-42.84%
Prepaid Expenses	1.66	1.03	2.04	1.95	2.17	2.32
Other Current Assets	-	1.11	0.01	0.01	0.01	0.01
Total Current Assets	15.43	17.25	27.71	20.55	41.82	29.47
Property, Plant & Equipment	0	0.02	0.05	0.09	-	-
Other Long-Term Assets	0.17	0.23	0.44	0.65	0.01	0.14
Total Assets	15.6	17.5	28.2	21.29	41.83	29.6
Accounts Payable	5.87	5.66	6.43	3.89	1.81	1.29
Accrued Expenses	4.79	8.19	9.14	9.02	7.16	4
Current Portion of Long-Term Debt	-	21.12	-	-	-	-
Current Portion of Leases	0.05	0.02	0.05	0.04	0.01	0.04
Other Current Liabilities	0.06	0.43	0.06	0.06	0.07	0.07
Total Current Liabilities	10.77	35.41	15.68	13.01	9.03	5.4
Long-Term Debt	122	85.11	71.74	39.83	29.05	-
Long-Term Leases	-	-	0.02	0.07	-	0.01
Other Long-Term Liabilities	-	0.05	1	0.57	1.13	-
Total Liabilities	132.77	120.57	88.44	53.48	39.21	5.41
Common Stock	0.06	0.06	0.06	0.06	0.06	0.06
Additional Paid-In Capital	299.32	296.22	291.85	275.08	271	261.88
Retained Earnings	-418.76	-401.57	-354.37	-309.57	-270.69	-240
Total Common Equity	-119.38	-105.29	-62.46	-34.43	0.37	21.94
Shareholders' Equity	-117.17	-103.07	-60.24	-32.19	2.62	24.19
Total Liabilities & Equity	15.6	17.5	28.2	21.29	41.83	29.6
Total Debt	122.05	106.25	71.81	39.93	29.06	0.05
Net Cash (Debt)	-108.28	-91.13	-46.15	-21.34	10.59	27.09
Net Cash Growth	-	-	-	-	-60.90%	-42.90%
Net Cash Per Share	-1.72	-1.46	-0.77	-0.36	0.18	0.48
Filing Date Shares Outstanding	64.06	63.18	61.9	59.44	59.36	57.16
Total Common Shares Outstanding	64.06	63.16	61.85	59.43	59.34	57.08
Working Capital	4.65	-18.16	12.03	7.54	32.79	24.07
Book Value Per Share	-1.86	-1.67	-1.01	-0.58	0.01	0.38
Tangible Book Value	-119.38	-105.29	-62.46	-34.43	0.37	21.94
Tangible Book Value Per Share	-1.86	-1.67	-1.01	-0.58	0.01	0.38
Machinery	-	0.07	0.07	0.07	0.07	0.07
Leasehold Improvements	-	0	0	0	0	0

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q